Dose-volumetric parameters and prediction of severe acute esophagitis in patients with locally-advanced non small-cell lung cancer treated with neoadjuvant concurrent hyperfractionated-accelerated chemoradiotherapy

समान संसाधन

• Comparison between late-course accelerated hyperfractionation radiotherapy and concurrent chemoradiotherapy in patients with esophageal carcinoma
  द्वारा: LIN, QIANG, और अन्य
  प्रकाशित: (2011)
• Implementation of durvalumab maintenance treatment after concurrent chemoradiotherapy in inoperable stage III non-small cell lung cancer (NSCLC)—a German radiation oncology survey
  द्वारा: Käsmann, Lukas, और अन्य
  प्रकाशित: (2020)
• A clinical trial of neoadjuvant concurrent chemoradiotherapy followed by resection for esophageal carcinoma
  द्वारा: Kazem Anvari, और अन्य
  प्रकाशित: (2015-01-01)
• Treatment outcomes of neoadjuvant concurrent chemoradiotherapy followed by esophagectomy for patients with esophageal cancer
  द्वारा: Kim, Yong-Hyub, और अन्य
  प्रकाशित: (2015)
• A clinical trial of neoadjuvant concurrent chemoradiotherapy followed by resection for esophageal carcinoma
  द्वारा: Anvari, Kazem, और अन्य
  प्रकाशित: (2015)